HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by PERVAIZ, S. Search for Related Content PubMed PubMed Citation Articles by PERVAIZ, S.

Reactive oxygen-dependent production of novel photochemotherapeutic agents

Department of Physiology, National University of Singapore, Singapore 117597

¹Correspondence: Department of Physiology, National University of Singapore, 2 Medical Dr., Singapore 117597. E-mail: phssp{at}nus.edu.sg

The reactive nature of species derived from oxygen, such as singlet oxygen and hydrogen peroxide, has been exploited in the clinical setting for targeting bacteria, viruses, and tumor cells by photodynamic excitation of a variety of chromophores. This modality, termed photodynamic therapy (PDT), is currently being used to treat some forms of cancer. However, the applicability of conventional PDT is limited due to the absolute dependence on simultaneous exposure of the target to the photoactive compound and light. In 1990, we demonstrated that the need for simultaneous exposure of the biological target to light and photosensitizer could be circumvented by prior exposure (activation) of the sensitizer molecule to light and its subsequent use as any other anti-cancer or anti-viral drug. By dint of the nature of the protocol, this process was termed preactivation. Since then, the generation of biologically active molecules in vitro by preactivation has been validated using a variety of chromophores, such as merocyanine 540, Photofrin II, and naphthalimide. Here we briefly review the role of reactive oxygen species in the photodynamic effect, and provide an explanation for the mechanism of preactivation. We propose that photo-oxidation not only provides a novel means for the generation of biologically active molecules, but could also explain, at least in part the mechanism of conventional PDT. It is likely that the light-dependent breakdown of the chromophore to generate novel active compounds, in addition to reactive oxygen species, also contributes to the photodynamic damage observed on simultaneous exposure of the chromophore and target tissue to light during PDT.–Pervaiz, S. Reactive oxygen-dependent production of novel photochemotherapeutic agents.

Key Words: PDT • photodynamic reaction • photosensitizer • mitochondrial permeability

This article has been cited by other articles:

				S. Caffieri, F. Di Lisa, F. Bolesani, M. Facco, G. Semenzato, F. Dall'Acqua, and M. Canton The mitochondrial effects of novel apoptogenic molecules generated by psoralen photolysis as a crucial mechanism in PUVA therapy Blood, June 1, 2007; 109(11): 4988 - 4994. [Abstract] [Full Text] [PDF]

				H.-Y. Lin, C.-T. Chen, and C.-T. Huang Use of Merocyanine 540 for Photodynamic Inactivation of Staphylococcus aureus Planktonic and Biofilm Cells Appl. Envir. Microbiol., November 1, 2004; 70(11): 6453 - 6458. [Abstract] [Full Text] [PDF]

				Z. Tong, G. Singh, and A. J. Rainbow Sustained Activation of the Extracellular Signal-regulated Kinase Pathway Protects Cells from Photofrin-mediated Photodynamic Therapy Cancer Res., October 1, 2002; 62(19): 5528 - 5535. [Abstract] [Full Text] [PDF]